allogeneic osteoblastic cells
Cell therapyexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Feb 1, 2014 (NCT02020590)
Timeline
Indications
Mechanism of action
- Unspecified targetTissue restoration
Tissue restoration
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- allogeneic osteoblastic cells
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02328287 | Phase 2 | Nov 1, 2014 | Bone Therapeutics S.A |
| NCT02205138 | Phase 2 | Oct 1, 2014 | Bone Therapeutics S.A |
| NCT02020590 | Phase 1/Phase 2 (Phase 2) | Feb 1, 2014 | Bone Therapeutics S.A |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Bone Therapeutics S.A | For profit | 3 | 3 | 1 | 2014 |
1 organizations
Page 1 / 1